ELV - Elevance Health, Inc.

QQQ $ 617.50 $ 6.52 (1.07 %)

DIA $ 472.45 $ 4.92 (1.05 %)

SPY $ 677.25 $ 5.49 (0.82 %)

TLT $ 91.47 $ 0.04 (0.04 %)

GLD $ 378.59 $ -1.27 (-0.34 %)

Previous Close

$ 342.35

Open

$ 347.01

Bid

$ 341.95 x 1

Ask

$ 345.10 x 20

Day's Range

$ 340.04 - $ 349.03

52 Week Range

$ 272.22 - $ 454.26

Volume

1,318,327

Average Volume

Market Cap

76.08B

Beta (5Y Monthly)

$ 0.56

PE Ratio (TTM)

$ 13.75

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.02)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	10-21-2025	09-30-2025	10-Q
2	07-17-2025	06-30-2025	10-Q
3	04-22-2025	03-31-2025	10-Q
4	02-20-2025	12-31-2024	10-K
5	10-17-2024	09-30-2024	10-Q
6	07-17-2024	06-30-2024	10-Q
7	04-18-2024	03-31-2024	10-Q
8	02-21-2024	12-31-2023	10-K
9	10-18-2023	09-30-2023	10-Q
10	07-19-2023	06-30-2023	10-Q
11	04-19-2023	03-31-2023	10-Q
12	02-15-2023	12-31-2022	10-K
13	10-19-2022	09-30-2022	10-Q
14	07-20-2022	06-30-2022	10-Q
15	04-20-2022	03-31-2022	10-Q
16	02-16-2022	12-31-2021	10-K
17	10-20-2021	09-30-2021	10-Q
18	07-21-2021	06-30-2021	10-Q
19	04-21-2021	03-31-2021	10-Q
20	02-18-2021	12-31-2020	10-K
21	10-28-2020	09-30-2020	10-Q
22	07-29-2020	06-30-2020	10-Q
23	04-29-2020	03-31-2020	10-Q
24	02-19-2020	12-31-2019	10-K
25	10-23-2019	09-30-2019	10-Q
26	07-24-2019	06-30-2019	10-Q
27	04-24-2019	03-31-2019	10-Q
28	02-20-2019	12-31-2018	10-K
29	10-31-2018	09-30-2018	10-Q
30	07-25-2018	06-30-2018	10-Q
31	04-25-2018	03-31-2018	10-Q
32	02-21-2018	12-31-2017	10-K
33	10-25-2017	09-30-2017	10-Q
34	07-26-2017	06-30-2017	10-Q
35	04-26-2017	03-31-2017	10-Q
36	02-22-2017	12-31-2016	10-K
37	11-02-2016	09-30-2016	10-Q
38	07-27-2016	06-30-2016	10-Q
39	04-27-2016	03-31-2016	10-Q
40	02-19-2016	12-31-2015	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Assessing Elevance Health: Insights From 1...
10/23/2025 19:01:08

centene-and-oscar-health-stocks-sink-after-molina-warning

Centene And Oscar Health Stocks Sink After...
10/23/2025 17:30:20

US healthcare insurance providers Centene and Oscar Health stocks are down after Molina Healthcare reported disappointing guida...

TD Cowen Maintains Buy on Elevance Health,...
10/23/2025 15:21:46

TD Cowen analyst Ryan Langston maintains Elevance Health (NYSE:ELV) with a Buy and raises the price target from $330 to $380.

Wells Fargo Maintains Overweight on Elevan...
10/22/2025 13:28:30

Wells Fargo analyst Stephen Baxter maintains Elevance Health (NYSE:ELV) with a Overweight and lowers the price target from $...

Barclays Maintains Overweight on Elevance ...
10/22/2025 12:56:47

Barclays analyst Andrew Mok maintains Elevance Health (NYSE:ELV) with a Overweight and lowers the price target from $395 to ...

elevance-healths-strong-quarter-cant-shake-off-medicaid-troubles

Elevance Health's Strong Quarter Can't Sha...
10/21/2025 18:54:07

Elevance Health beats estimates, but shares fall due to Medicare pressures, Obamacare changes, and Medicaid attrition.

gold-sinks-5-on-worst-day-in-5-years-dow-jones-hits-record-highs-whats-moving-markets-tuesday

Gold Sinks 5% On Worst Day In 5 Years, Dow...
10/21/2025 16:23:50

Gold prices suffered a sharp correction on Tuesday as investors locked in profits following this year's explosive rally, wh...

Elevance Health Exec Says The Anticipated ...
10/21/2025 13:32:43

- Conf Call

Elevance Health Raises FY2025 GAAP EPS Gui...
10/21/2025 10:02:52

Elevance Health (NYSE:ELV) raises FY2025 GAAP EPS guidance from $24.10 to $24.70 vs $25.24 analyst estimate..

Elevance Health Affirms FY2025 Adj EPS Gui...
10/21/2025 10:02:30

Elevance Health (NYSE:ELV) affirms FY2025 Adj EPS guidance from $30.00 to $30.00 vs $29.90 analyst estimate..

Elevance Health Q3 Adj. EPS $6.03 Beats $4...
10/21/2025 10:01:05

Elevance Health (NYSE:ELV) reported quarterly earnings of $6.03 per share which beat the analyst consensus estimate of $4.93 by...

Earnings Scheduled For October 21, 2025
10/21/2025 08:32:17

Exploring Elevance Health's Earnings Expec...
10/20/2025 15:02:41

humana-loses-court-battle-over-medicare-advantage-ratings-billions-in-payments-at-risk

Humana Loses Court Battle Over Medicare Ad...
10/14/2025 18:38:50

Texas court rules against Humana, upholding Medicare Advantage bonus cuts and risking billions in insurer revenue tied to star ...

Morgan Stanley Maintains Equal-Weight on E...
10/14/2025 15:52:19

Morgan Stanley analyst Erin Wright maintains Elevance Health (NYSE:ELV) with a Equal-Weight and raises the price target from...

Goldman Sachs Initiates Coverage On Elevan...
10/14/2025 12:40:07

Goldman Sachs analyst Scott Fidel initiates coverage on Elevance Health (NYSE:ELV) with a Neutral rating and announces Pric...

B of A Securities Maintains Neutral on Ele...
10/10/2025 15:49:53

B of A Securities analyst Kevin Fischbeck maintains Elevance Health (NYSE:ELV) with a Neutral and raises the price target fr...

What's Driving the Market Sentiment Around...
10/10/2025 15:00:58

Mizuho Maintains Outperform on Elevance He...
10/09/2025 12:56:55

Mizuho analyst Ann Hynes maintains Elevance Health (NYSE:ELV) with a Outperform and raises the price target from $342 to $420.

Barclays Maintains Overweight on Elevance ...
10/09/2025 12:13:21

Barclays analyst Andrew Mok maintains Elevance Health (NYSE:ELV) with a Overweight and raises the price target from $373 to ...